Zobrazeno 1 - 5
of 5
pro vyhledávání: '"R. G. G. Russel"'
Autor:
R. G. G. Russel, S. M. Krane
Publikováno v:
Rheumatology. 32:1-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c58ad70f5443bad2db8622c5c23bf93
https://doi.org/10.1093/rheumatology/32.suppl_2.1
https://doi.org/10.1093/rheumatology/32.suppl_2.1
Autor:
G. Plomteux, F. Cornet, G. Cession-Fossion, J. A. Kanis, S. Gaspar, Paul Franchimont, R. G. G. Russel, G. Heynen
Publikováno v:
Acta Endocrinologica. 98:619-624
Effects of small iv doses of 1.25-dihydroxy-and 24.25-dihydroxy-vitamin D3 (1 μg) were studied in 10 normal subjects. Injection of 1.25 (OH)2D3 was associated with small but significant increases in plasma calcium and phosphate but plasma levels of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f336bc27b451137180476c510af4bb6
https://doi.org/10.1530/acta.0.0980619
https://doi.org/10.1530/acta.0.0980619
Autor:
D. O. Oliver, R. G. G. Russel, Richard J.H. Smith, J. A. Kanis, R. G. Henderson, J. G. G. Ledingham, R. J. Walton
Publikováno v:
Calcified Tissue Research. 21:221-225
Recent short-term studies have shown that microgram doses of both 1,25-dihydroxycholecalciferol (1,25-(OH)2-D3), the hormonally active metabolite of vitamin D, and lα-hydroxycholecalciferol (lα-OH-D3), a synthetic analogue can increase intestinal a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::679e96d03c83ff38397ef5472d57f712
https://doi.org/10.1007/bf02546453
https://doi.org/10.1007/bf02546453
Autor:
R. G. Henderson, J. A. Kanis, J. G. G. Ledingham, D. O. Oliver, R. G. G. Russel, R. Smith, R. J. Walton
Publikováno v:
Calcified Tissues 1975 ISBN: 9783662277768
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::831ae2699c6b4f371c777e1d1f0dd308
https://doi.org/10.1007/978-3-662-29272-3_32
https://doi.org/10.1007/978-3-662-29272-3_32
Publikováno v:
Fortschritte der Urologie und Nephrologie ISBN: 9783798506084
Inorganic pyrophosphate is an inhibitor for formation of crystals with stone forming salts (Fleisch, 1978).. Pyrophosphate excretion is influenced by the kidney (Russel et al., 1976). We have shown that recurrent renal stone formers often have tubula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2246d4cd5c22e20c90e97a5ae6c2cee2
https://doi.org/10.1007/978-3-642-72360-5_73
https://doi.org/10.1007/978-3-642-72360-5_73